JUBOBS LIMITED

Executive Summary

JUBOBS LIMITED is a newly formed micro-entity operating in the human health sector with timely filings and positive net current assets. While initial solvency appears sound and governance is straightforward, the lack of operational history, minimal assets, and no employees warrant further inquiry into business sustainability and cash flow. Overall, risk is low at this early stage but will require ongoing monitoring as business activities develop.

JUBOBS LIMITED - Analysis Report

Company Number: 15399739

Analysis Date: 2025-07-29 15:51 UTC

1. Risk Rating: LOW

Justification: The company is newly incorporated (January 2024) and has filed its first set of micro-entity accounts on time without overdue filings. The balance sheet shows positive net current assets (£6,493) and no long-term liabilities, indicating initial solvency and no immediate liquidity issues. The director is also the sole significant controller, suggesting centralized oversight.

2. Key Concerns:

• Limited financial history: As a start-up with only one financial year completed, there is insufficient data to assess operational performance or trends.
• Minimal assets and no fixed assets: The company has no fixed assets and only modest current assets, which may limit operational capacity and flexibility.
• Zero employees: No staff are recorded, implying reliance on the director or contractors; sustainability of operations may depend heavily on this structure.

3. Positive Indicators:

• Compliance: All statutory filings (accounts and confirmation statement) are up to date with no overdue issues, reflecting good governance.
• Positive working capital: Current assets exceed current liabilities by a reasonable margin for a micro-entity.
• Clear ownership and control: Single director and 75-100% ownership concentration reduce governance complexity.

4. Due Diligence Notes:

• Investigate business model and revenue generation plans given no employees and minimal assets.
• Review cash flow forecasts and funding sources to ensure liquidity beyond the current modest cash position.
• Confirm no regulatory or compliance issues beyond Companies House filings, especially given the health sector SIC codes which may involve additional licensing or registrations.